Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.23 | Prev. Close $0.25 | Circuit Range N/A |
Day Range $0.23 - $0.23 | Year Range $0.11 - $2.66 | Volume 4,174 |
Average Traded $0.23 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $0.24 | $0.24 | +2.51% |
07-Apr-26 | $0.22 | $0.24 | +0.42% |
06-Apr-26 | $0.24 | $0.24 | +3.03% |
02-Apr-26 | $0.23 | $0.23 | -4.55% |
01-Apr-26 | $0.23 | $0.24 | +2.98% |
31-Mar-26 | $0.24 | $0.23 | -2.49% |
30-Mar-26 | $0.24 | $0.24 | -1.23% |